Abstract
Visual alterations under classic psychedelics can include rich phenomenological accounts of eyes-closed imagery. Bottom-up connectivity of the visual pathway underpins sensory perception, with top-down connectivity enhanced during intentional imagery. Preclinical evidence suggests agonism of the 5-HT2A receptor may reduce synaptic gain to produce psychedelic induced-imagery. However, this has not been investigated in humans. To infer the directed connectivity changes to visual sensory connectivity underlying psychedelic visual imagery, we applied dynamic causal modelling to the resting state eyes-closed functional MRI scans of healthy adults after administration of psilocybin or placebo. The model included early visual regions, fusiform gyrus, intraparietal sulcus, and inferior frontal gyrus. We observed a pattern of increased self-inhibition of both early visual and higher visual-associative regions under psilocybin. The increased self-inhibition was associated with behavioural measures of complex and elementary imagery, and a pattern of reduced excitation and inhibition from visual-associative regions to earlier visual areas. The results are consistent with preclinical findings and inform our understanding of clinical hallucinations and perception, and suggest deprivation of sensory activity may amplify endogenous associative neural activity. The findings inform the neurobiology of psychedelic-induced changes to sensory connectivity and the neural mechanisms associated with closed-eyes visual imagery.
Introduction
When we close our eyes our imagination allows us to visualise imagery beyond the constraints of open-eyes perception. However, our capacity to visualise closed-eyes imagery is typically limited during our waking state. When a serotonergic psychedelic is ingested, closed-eyes visual alterations may manifest more vividly and take on a variety of forms. Investigation of the neural mechanisms of psychedelic-induced closed-eyes visual imagery (i.e., hallucinations) probes the relationship between neuropharmacology and large-scale neural connectivity of the visual system. Embedding non-voluntary (i.e., hallucinated) imagery into an experimental design using psychedelics overcomes the unpredictable occurrence of hallucinations in clinical disorders (Teufel, 2018) and can help inform our understanding of perception and clinical hallucinations.
Vision is often associated with the outside world, which seems to disappear when we close our eyes. However, the visual perception differences we perceive between states of eyes-open and -closed may depend upon inhibitory neural mechanisms. Preclinical studies have demonstrated that when our eyes are closed alpha waves (8-12 Hz range) inhibit activity in the visual system (Billock & Tsou, 2007; Klimesch, 2011). Building on this knowledge and the phenomenology of psychedelic visual alterations, Kometer and Vollenweider, 2013 measured the influence of psilocybin on alpha inhibition (Michael Kometer, Schmidt, Jäncke, & Vollenweider, 2013; Watakabe et al., 2009). Their experiments revealed that psilocin, the active metabolite of psilocybin found in psychedelic mushrooms, inverted (i.e., dampened) the response of occipital-parietal alpha oscillations to eyes-open and eyes-closed states (Michael Kometer et al., 2013). This was associated with reduced attention to sensory stimuli during eyes open tasks and decreased alpha inhibition during eyes closed periods. Resting state functional connectivity studies have shown that during eyes-closed the early visual system (corresponding to primary visual cortex) responds to the synthetic psychedelic compound lysergic diethylamide acid (LSD) as if it were receiving localised spatial inputs (Roseman et al., 2016). This evidence suggests the importance of neural mechanisms in the perception of our visual world.
Perception research has also shown stimulus-triggered perception and internally generated visual imagery relies on similar neural mechanisms (Fazekas, Nemeth, & Overgaard, 2020). Activity of sensory connectivity in closed-eyes states, such as sleep, may help explain the vividness of visual stimuli experienced in dreams. Moreover, under psychedelics some participants report negligible difference between the vividness of eyes open and eyes closed stimuli (Cott & Rock, 2008; de Araujo et al., 2012; Shanon, 2002). Brain states during dreams and under serotonergic psychedelics show similarities in the reduced low frequencies in parietal-occipital regions (Siclari et al., 2017; Timmermann et al., 2019). However, the manifestation of visual imagery with eyes-closed is not yet fully understood.
The consciousness altering properties of psychedelics can facilitate investigations into mechanisms that underpin the quality of different states of consciousness. For example, pharmacological changes appear to underlie the distinction between wakefulness and sleep. A primary mechanism of the unconscious brain is the pattern of increased inhibition, often associated to GABA-ergic neuronal activity (among other mechanisms) which corresponds to increased low and reduced high energy frequencies (Bonhomme et al., 2019; Luppi et al., 2022). In contrast, the binding kinetics of psychedelic molecules to the serotonergic 5-HT2A receptor produce a net-excitatory effect and (inverse) change to energy of brain states associated with frequency-weighted contributions to cortical dynamics (Atasoy et al., 2017; Vollenweider & Smallridge, 2022).
The 5-HT2A receptor is highly expressed in visual and frontal areas of the brain. Under serotonergic psychedelics, frontal areas—associated to self-related thinking, planning and egocentric perspective— appear to reduce whole-brain functional connectivity (Preller et al., 2020). The decrease in functional connectivity of frontal regions has been associated with the effect of ego dissolution, loss of identity and separation from the world (Carhart-Harris et al., 2012; Smigielski, Scheidegger, Kometer, & Vollenweider, 2019; Vollenweider & Preller, 2020) (Stoliker et al., 2022). In contrast, visual areas of the brain undergo an opposite transformation and show increased functional connectivity (Preller et al., 2020). This large-scale inversion of temporal dynamics may underlie the perceptual experience of psychedelics (Vollenweider & Preller, 2020).
Preclinical research conducted using extracellular recordings and wide-field calcium imaging reported imbalanced 5-HT1A/2A activation reduced sensory drive of the mouse visual cortex (Azimi et al., 2020). Wide-field and two-photon calcium imaging and single-unit electrophysiology of mice under the 5-HT2AR agonist DOI (2,5-dimethoxy-4-iodoamphetamine) also found a net inhibition of visual response amplitude and surround suppression (i.e, the presence of neighboring stimuli diminish the neural response to a central visual stimulus) in the primary visual cortex, while the basic retinotopic organization and receptive fields were maintained (Schallmo & Murray, 2016)(Michaiel, Parker, & Niell, 2019). These findings suggest reduced sensory drive may enhance internal signaling by affecting the balance of bottom-up sensory information and top-down processing (Azimi et al., 2020; Michaiel et al., 2019). However, these phenomena have not yet been studied in human populations under psychedelic-induced 5-HT2A receptor agonism.
Under psychedelics, visual alterations or hallucinations may occur at different levels of complexity and realism. The most rudimentary forms include elementary imagery (i.e., hallucinations). Elementary imagery comprises light flashes, reorganising and moving line orientations and geometrical figures containing recurrent patterns (Oishi et al., 2003). These effects have been associated with the early visual areas (EVA; corresponding to the primary visual cortex) and may be accompanied by visual intensification such as increased brightness or contrast visual perception (M. Kometer & Vollenweider, 2018; Price, Whitlock, & Hall, 1983; Teeple, Caplan, & Stern, 2009). More phenomenologically rich visual alterations can occur under psychedelics to induce visualisations of scenes, people, and objects.
Visual alterations which involve more semantic content are identified as complex imagery and have been associated with visual associative connectivity (Price et al., 1983; Teeple et al., 2009). Complex imagery is also a form of visual hallucination witnessed in conditions of visual impairment such as Charles Bonnet Syndrome (Manford & Andermann, 1998; Menon, Rahman, Menon, & Dutton, 2003). Complex imagery and elemental imagery can be assessed independently using the five dimensions of altered states of consciousness scale (Studerus, Gamma, & Vollenweider, 2010), (see Supplementary for further information).
This study investigated regions of the visual system previously established in mental imagery including the EVA, fusiform gyrus (FG), intraparietal sulcus (IPS) and inferior frontal gyrus (IFG) (N. Dijkstra, Zeidman, Ondobaka, van Gerven, & Friston, 2017). The EVA is the first stage of cortical visual processing and has demonstrated increased top-down connectivity from visual-associative regions to the EVA during eyes-closed visual imagery tasks (N. Dijkstra, Zeidman, Ondobaka, van Gerven, & Friston, 2017). Connectivity from the EVA follows two broad pathways. The dorsal pathway is connected with the fusiform gyrus (FG), part of the inferior temporal cortex that functions to recognise objects and faces (Blatt, 2013). The ventral pathway from the EVA is connected to the intraparietal sulcus (IPS). The investigation includes the inferior frontal gyrus (IFG) as both the IPS and IFG are involved in cognitive aspects of imagery. We hypothesised increased self-inhibition and reduced excitatory connectivity of regions in the model. Specifically, that EVA self-connectivity would be associated with elementary imagery and top-down (i.e., feedback or inside-out) directed connectivity of higher visual areas involved in associative and semantic content would be associated with complex imagery.
Results
We report effective connectivity results in the visual pathways under both placebo and psilocybin conditions, and the association of the effectivity with elementary and complex imagery scores obtained after the resting state scan.
Results are reported as the mean effective connectivity of conditions without application of global signal regression (GSR). Multiple design matrices without and with GSR are reported in the supplementary material (See Fig S3, S4 and S5). In DCM, self-connections are modelled as inhibitory and log-scaled (see supplementary material for brief technical explanation). Self-connections control the regions’ gain or sensitivity to inputs and the synaptic gain or sensitivity of a region to inputs. A positive self-connection means a relative increased inhibition of the region to external inputs, whereas a negative self-connection means a relative decreased inhibition (i.e., disinhibition) and increased sensitivity to inputs. The self-connections are log-scaled in DCM.
Visual pathway effective connectivity under placebo
Group-level mean effective connectivity between regions of the visual pathway show inhibition from the IFG to the IPS, FG and EVA. Self-inhibition of the EVA is accompanied by excitation from the FG to the EVA (Fig 1). The results were unchanged with or without GSR (Figs S4 and S5 for results with global signal regression).
Visual pathways under psilocybin
Group-level mean effective connectivity between regions of the visual pathway show inhibition from the IFG to the IPS, FG and EVA, as well as between all connections to the EVA, except for the FG to EVA, which was excitatory. Self-connectivity of all regions is inhibitory, particularly within the EVA and regions of the inferior temporal cortex (FG and IFG) which showed increased inhibitory recurrent connectivity. See Fig 2. See Fig S1 for detailed group level region effective connectivity matrix and Table S1 for credible intervals.
Behavioural associations to effective connectivity under psilocybin
Behavioural scores acquired after the scans measured elemental imagery and complex imagery. Associations between group-level mean effective connectivity and elemental and complex imagery were analysed. Self-inhibition of the FG and inhibitory connectivity from the FG to the IFG were associated with elemental imagery. Self-inhibition of the EVA and FG, and connectivity from the FG to EVA were associated with complex imagery. Complex imagery was also associated with the inhibition of the IFG to the IPS. See Fig 3 and Fig S2 for the respective connectivity matrices.
Discussion
When we open our eyes, visual perception is driven from the outside world. However, consciousness and philosophical research has identified the significant role of the brain in constructing visual perception. Hermann von Helmholtz said, “Objects are always imagined as being present in the field of vision as would have to be there in order to produce the same impression on the nervous mechanism”. This suggests visual perception manifests as an inference based on the activity of the nervous system. Our limited foveal acuity and the filtration processes of the (subcortical) brain inhibit the granularity of information reaching conscious awareness, which requires visual perception to rely on top-down beliefs and expectations. Expectations that influence perceptual may be conscious and learned—for example, prior expectations have been shown to facilitate hallucinations (Corlett et al., 2019)—or may be unconscious and innate, demonstrated by visual illusions and perceptual biases, such as the Adelson’s checker-shadow illusion (Huff, Mahabadi, & Tadi, 2022). Our investigation measured the large-scale expression of neuropharmacological changes on brain connectivity to give insights into the neural mechanisms that underlie psychedelic induced changes to visual connectivity and the perception of eyes-closed visual imagery under psychedelics.
The findings revealed that a pattern of inhibition in self-connections of visual pathways underlie the effects of psilocybin. DCM estimated inhibition in the self-connections of all regions in our model, which reflects the reduced synaptic gain of the regions. Moreover, self-inhibition of specific regions, such as the EVA and FG, were demonstrated in association with complex and elemental imagery. The FG is strongly involved in the processing and recognition of objects and faces (Blatt, 2013), while the EVA receives, segments, and integrates visual information (Huff et al., 2022). We also found top-down connectivity from the FG to EVA associated with complex imagery and damage to this connectivity has previously been associated with Charles Bonnet syndrome hallucinations (Pang, 2016).
Inhibition of visual-associative connectivity were also associated with complex imagery. This was demonstrated by the top-down inhibitory connectivity from IFG to IPS. The IFG has a role in cognitive processes during visual working memory (Gazzaley & Nobre, 2012) and the IPS is involved in visual attention and the maintenance and manipulation of spatial information in working memory (Bray, Almas, Arnold, Iaria, & MacQueen, 2013).
Previous fMRI research of healthy adults estimated the effective connectivity of voluntarily imagined objects (N. Dijkstra et al., 2017). This research indicated group activity from the IFG to the EVA was more excitatory when objects were imagined versus visually observed and suggested sensory perception is underwritten by feedforward connectivity while imagery is underwritten by feedback connectivity. Our findings show inhibition of the IFG to EVA under psilocybin is less than placebo. The difference—while trending in the same direction (less inhibitory)—may mark the difference between task-based imagery that requires intentional imagination and our experimental design which measured spontaneous psilocybin-induced visual imagery. Moreover, the IFG showed greater top-down connectivity under psilocybin, demonstrated by its efferent connections (See Fig. 1 and Fig. 2).
Our results align with earlier preclinical findings under agonism of the 5-HT2AR that suggest reduced sensory drive augment internal transmissions (Azimi et al., 2020; Michaiel et al., 2019). Reduced sensory drive appears to generalise to the effective connectivity of the human visual system under psilocybin and suggests the augmentation of internal signals may induce visual imagery, in the absence of eyes open sensory stimuli. The increased self-inhibition of visual and associative regions indicates reduced synaptic gain that corresponds to the decreased sensitivity of the regions to inputs. The decreased synaptic gain may relate to previous findings of reduced parieto-occipital alpha oscillations measured in the 8-12Hz band under psilocybin, which may facilitate spontaneous activation in eyes-closed states that contributes to visual imagery (Michael Kometer et al., 2013; M. Kometer & Vollenweider, 2018). Decreased synaptic gain may also be associated with synchronised temporal patterns of sensory activity identified by functional connectivity analysis (Katrin H. Preller et al., 2020). Similarly, work in the mouse V1 suggests agonism of the 5-HT2AR alters temporal dynamics while preserving basic retinotopic organization, tuning properties, and receptive fields (Michaiel et al., 2019). The maintenance of these properties and altered functional connectivity may also explain previously observed patterns of EVA activity that resembled localised spatial inputs under psychedelics, during eyes-closed resting state imaging (Roseman et al., 2016). The combination of reduced sensory drive, alpha inhibition, preserved visual characteristics and altered temporal dynamics may provide the conditions for visual imagery. However, further study exploring visual connectivity and informed synthesis of findings from various experimental techniques is required in humans to verify the neural mechanisms of psychedelic imagery.
A popular model of psychedelic altered consciousness, the RElaxed Beliefs Under pSychedelics (REBUS model), (R. L. Carhart-Harris & Friston, 2019; Katrin H. Preller et al., 2020), suggests reduced top-down connectivity and increased the bottom-up connectivity underlies the relaxation of beliefs that can occur under psychedelics. This model fits with the pattern of temporal desynchronisation of associative connectivity measured under psilocybin and suggests that psychedelics attenuate predictions carried by top-down connectivity from associative areas to hierarchically lower levels of the brain (R. L. Carhart-Harris & Friston, 2019; Katrin H. Preller et al., 2020). This is suggested to enable increased bottom-up connectivity from hierarchically lower sensory areas and allow the relaxation of prior beliefs. Our findings of reduced synaptic visual gain do not directly support the bottom-up principle of this model. However, the reduced gain of regions in our model may accentuate cognitive and emotional signals that manifest in the content of visual imagery. For example, schizophrenia research—which investigated different pharmacological mechanisms—describes that impaired sensory input may allow attentional mechanisms a preponderant role that lead to hallucinations (Boksa, 2009). Similar mechanisms may underlie psychedelic visual imagery. In other words, reduced sensory drive may create a neuronal state which more readily processes endogenous signals as visual content, much like dreams. Moreover, alpha waves, which are suggested to inhibit brain regions not undergoing operations, disappear during sleep— although their role during dreams remains ambiguous (Moini & Piran, 2020; RUBY et al., 2013; Scarpelli, D’Atri, Gorgoni, Ferrara, & De Gennaro, 2015). Reduced alpha-inhibition may disinhibit the sensitivity constraints of visual perturbations. For example, the experience of sensory synaesthesia, such as visual imagery driven by music, is common under psychedelics (Kaelen et al., 2016). These subjective effects suggest the increased integration of sensory connectivity.
Previous DCM analysis measured the interaction between music and LSD and found increased visual imagery associated with reduced constraints of parahippocampus connectivity to the visual cortex (Kaelen et al., 2016). Further investigation of limbic regions may benefit the understanding of visual imagery. For example, interactions between limbic regions are involved in visual scene recognition and spatial awareness: the retrosplenial cortex, anterior hippocampus, parahippocampus and entorhinal cortex share roles in egocentric and allocentric perspective and spatial aspects of imagery (Alexander Andrew et al.; Doeller & Kaplan, 2011; Kim & Maguire, 2018; Vann, Aggleton, & Maguire, 2009). Moreover, areas such as the hippocampus demonstrate lower glutamate levels under psilocybin and are associated with positive experiences (Mason et al., 2020). Future effective connectivity research investigating associative and limbic regions connectivity to the visual system that examine the content of psychedelic experiences may help establish the neural mechanism underlying the visual content of psychedelic experiences.
Psychedelic experiences are often interpreted through the experience of imagery, which can be composed of meaningless (sometimes absurd) content or semantically meaningful content. The effect of dose, subjective mindset and environmental setting may reveal patterns that determine the meaningfulness of psychedelic visual content. For example, psychedelic visual imagery noted in therapeutic trials occasionally describe complex visual imagery that take on personal meaning that may be important catalysts of therapeutic changes (Malone et al., 2018). Moreover, examining visual-associative connectivity involved in memory and emotion can inform consciousness and perception research.
Future research may also wish to measure effective connectivity changes between visual and associative regions at higher doses of psychedelics to better understand the function of integration between sensory and associative connectivity. For example, it has been suggested that the difficulty differentiating whether the source of a signal represents reality or imagination, known as reality monitoring, may depend upon top-down connectivity to earlier visual areas (N. Dijkstra, Kok, P., & Fleming, S. M., 2021). Higher doses of psilocybin which result in experiences of ego dissolution and related out of body experiences may give insight into the mechanisms that underlie these symptoms in clinical disorders. We found the IFG which serves a role in cognitive processes during visual working memory (Gazzaley & Nobre, 2012) was diminished under psilocybin. The association of top-down connectivity from the IFG to EVA may also be an important mechanism for reality monitoring that future research could measure for signs of change at higher psilocybin doses.
Psychedelic-induced imagery may also be experimented with aphantasic populations. Aphantasia describes the inability to visualise imagery and has been associated with anterior parietal connectivity (Milton et al., 2021). Measuring the change in brain connectivity and the subjective amplification of imagery in subjects with aphantasia, or hyperphantasia, under psychedelics remains an exciting research prospect.
Our investigation of imagery in a healthy population under psilocybin has several limitations. The selection of regions and coordinates of the regions may affect the results. Replication using the same regions is recommended. Future research may explore alternate selection of regions and, methods of determining their coordinates. For example, the cuneus, precuneus, posterior parietal, lingual, and lateral occipital gyrus are visual regions that serve important functions, often distinguished by the dorsal and ventral visual pathways and were not investigated in this analysis. Imaging that accommodate subjective differences in the onset of visual imagery is also recommended. Future research may also supplement placebo control designs with unblinded “baseline” imaging prior to the administration of psilocybin. Imagery tasks may also facilitate group-specific activations and the identification of coordinates in the regions of interest. Dose can also strongly impact the results. Participants were given less than a standard clinical dose of psilocybin typically used during therapeutic interventions (i.e., 25 mg). The vividness of imagery and connectivity dynamics may be dissimilar at a higher dose, which is likely to produce greater connectivity differences in the visual system associated with higher psychedelic imagery scores. Score distribution on our measures of the 5D-ASC may also be a limitation. Participants responded to imagery measures on a button box that constrained group scores to a 1-4 scale. The limited granularity of the score distribution may affect the analysis of behavioural associations between connectivity and imagery. However, alignment between the time of imaging and behavioural measurement ensured the altered visual experience occurred during the scan. Our small healthy adult sample (n=20) (after thresholding for head motion) is also a limitation. Larger group sizes may benefit the reliability of results and are recommended for future research.
Conclusion
When we close our eyes, sensory stimulation is inhibited, and we experience a sense of separation from the outside world. In this research we demonstrated neural mechanisms of the visual system altered by psychedelics that may cause visual perceptions in the absence of external stimulation. We found inhibition of visual brain regions and decreased excitatory effective connectivity across these regions under psilocybin. Our results extend previous preclinical research that found 5-HT2AR inhibits activity of visual regions. Visual regions have been previously associated with imagery and we demonstrated psilocybin effective connectivity in association with complex and elemental imagery. By altering perception, psychedelics provide a means of measuring the mechanisms responsible for making perceptual sense of the world. The ability of psychedelics to induce visual alterations and imagery expand the opportunity for perception and clinical research. Imagery in closed-eye states suggests psychedelics affect the brain’s function to discriminate the subjective from the objective world that fits into an overarching theme of reduced subject-object boundaries under psychedelics.
Methods
Participants
The data analysed in this paper were collected as part of a previous study (registered at ClinicalTrials.gov (NCT03736980)), which is reported in (Preller et al., 2017) and was approved by the Cantonal Ethics Committee of Zurich. 24 subjects (12 males and 11 females; mean age = 26.30 years; range = 20–40 years) were recruited through advertisements at universities in Zurich, Switzerland. See supplementary material for further detail.
Design
The data was part of a double blind, randomised, placebo-controlled, cross-over study. Resting state scans (10 minutes each) were taken 20, 40 and 70 minutes following administration of psilocybin or placebo. However, only scans at 70 minutes during the peak effects were used in the analysis. Participants were asked to not engage in repetitive thoughts such as counting. Furthermore, participants were asked to close their eyes during the resting state scan. A short version of the 5 Dimensions of Altered States of Consciousness Scale (5D-ASC, a retrospective self-report questionnaire) (Dittrich, 1998) was administered immediately after the scan to assess the time course of subjective effects. The questions were displayed with MR-compatible video goggles Resonance Technology Inc., Northridge, USA). Participants answered the questions on a scale ranging from 1 (not at all) to 4 (very much) using a 4-button response box.
MRI Data Acquisition and Preprocessing
MRI data were acquired on a Philips Achieva 3.0T whole-body scanner. A 32-channel receive head coil and MultiTransmit parallel radio frequency transmission was used. Images were acquired using a whole-brain gradient-echo planar imaging (EPI) sequence (repetition time, 2,430 ms; echo time, 27 ms; slice thickness, 3 mm; 45 axial slices; no slice gap; field of view, 240 × 240 mm2; in-plane resolution, 3 × 3 mm2; sensitivity-encoding reduction factor, 2.0). 265 volumes were acquired per resting state scan resulting in a scan duration of 10 mins. Additionally, two high-resolution anatomical images (voxel size, 0.7 × 0.7 × 0.7 mm3) were acquired using T1-weighted and T2-weighted sequences using 3D magnetization prepared rapid-acquisition gradient echo sequence (MP-RAGE) and a turbo spin-echo sequence, respectively. See Supplementary for more details. The acquired images were analysed using SPM12 (Ashburner et al., 2014).
The pre-processing steps of the images consisted of slice-timing correction, realignment, spatial normalization to the standard EPI template of the Montreal Neurological Institute (MNI), and spatial smoothing using a Gaussian kernel of 6-mm full-width at half maximum. Head motion was investigated for any excessive movement. Three subjects were excluded due to excessive head motion and one subject did not complete the scan at 70 minutes so eventually 20 subjects entered our connectivity analysis pipeline.
Extraction of region coordinates across subjects
Regions, model complexity and ROI size were selected based on prior literature (N. Dijkstra et al., 2017; Ishai, Haxby, & Ungerleider, 2002; Kalkstein, Checksfield, Jacob Bollinger, & Gazzaley, 2011; Reddy, Tsuchiya, & Serre, 2010). A generalized linear model (GLM) was used to regress 6 head motion parameters (3 translation and 3 rotational), white matter and cerebrospinal fluid signals from preprocessed data. Global signal regression (GSR) was not used in our pre-processing pipeline to align with visual research of the 2A receptor (Azimi et al., 2020; Michaiel et al., 2019). However, the results without GSR are reported in supplementary material to provide consistency with line with our previous investigations (Stoliker et al., 2022a,b). The time series for each ROI was computed as the first principal component of the voxels activity within an 8 mm sphere centred on the region of interest (ROI) coordinates listed in Table 1.
Specification and Inversion of DCM
Dynamic causal modelling (DCM) enables measurement of the direction of connectivity among circuits, which relies on Bayesian model comparison demonstrated to discriminate between inhibition and excitation of bottom-up and top-down connections (Bastos et al., 2015; Razi, Kahan, Rees, & Friston, 2015). This analysis technique allows non-invasive inference of the directed connectivity and self-connectivity (i.e., synaptic activity).
A fully-connected DCM model was specified using the four ROIs identified in Table 1, without any exogenous inputs. The DCM for each subject was then inverted using spectral DCM (Friston, Kahan, Biswal, & Razi, 2014; Razi et al., 2015) to infer the effective connectivity that best explains the observed cross-spectral density for each subject. The DCM fit to the data using cross spectral density averaged 87.3% for placebo conditions and 86.3% for psilocybin conditions.
Second Level Analysis Using Parametric Empirical Bayes
The effective connectivity inferred by spectral DCM for each subject is taken to the second (group) level to test hypotheses about between-subject effects. A Bayesian General Linear Model (GLM) is employed to characterise individual differences in effective connectivity into hypothesised group-average connection strengths plus any unexplained noise. Hypotheses on the group-level parameters are tested within the Parametric Empirical Bayes (PEB) framework (Friston et al., 2016), where both the expected values and the covariance of the connectivity parameters are taken into account. That is, precise parameter estimates influence the group-level result more strongly than uncertain estimates, which are down-weighted. We further employed Bayesian model reduction as an efficient automatic search to perform Bayesian model selection (Friston et al., 2016).
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Footnotes
↵+ Joint Senior Authors